Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;84(9):2761-5.
doi: 10.1073/pnas.84.9.2761.

Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3

Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3

A F Lopez et al. Proc Natl Acad Sci U S A. 1987 May.

Abstract

Cloned gibbon interleukin 3 (gIL-3) was found to stimulate the proliferation and differentiation of human bone marrow cells to produce day-14 granulocyte, macrophage, granulocyte-macrophage, and eosinophil colonies in semisolid agar. In the presence of normal human plasma, gIL-3 stimulated megakaryocytes. In methylcellulose cultures, it stimulated erythroid colonies in the presence, but not in the absence, of erythropoietin. When mature human leukocytes were used, gIL-3 stimulated the function of purified mature eosinophils as measured by the capacity to kill antibody-coated target cells, to produce superoxide anions, and to phagocytize opsonized yeast particles in a manner similar to recombinant human granulocyte-macrophage colony-stimulating factor. In contrast, gIL-3 did not significantly stimulate any of the neutrophil functions tested, whereas human recombinant granulocyte-macrophage colony-stimulating factor was active in these assays. Among cytokines that are active on human hematopoietic cells, gIL-3 thus has a distinct set of functions and may predict the range of actions of the human molecule.

PubMed Disclaimer

References

    1. J Immunol. 1975 Dec;115(6):1650-6 - PubMed
    1. J Immunol. 1979 Apr;122(4):1228-36 - PubMed
    1. J Immunol. 1983 Feb;130(2):795-9 - PubMed
    1. J Exp Med. 1983 Jun 1;157(6):1828-43 - PubMed
    1. J Immunol. 1983 Jul;131(1):282-7 - PubMed

Publication types

MeSH terms